1-(2-Bromothiazol-4-yl)ethan-1-one, 98%, 100mg

Gluconic acid potassium salt, min. 99%, for synthesis, 500 g, plastic packaging.

6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3R)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine, 98.0%, 10mg

2-Bromo-1-methoxy-3-methylbenzene, 95.0%, 250mg

2-Amino-2-(4-bromophenyl)acetic acid, 95.0%, 10g

1-Boc-4-(5-Methyl-1,3,4-oxadiazol-2-yl)piperidine, 95.0%, 100mg

2-Methoxynaphthalene, 95.0%, 25g

(R)-3-Bromo-2-methylpropan-1-ol, 98+%, 100mg

2-(Pyridin-3-yl)aniline, 95.0%, 5g

(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate, 98%, 5g

(2E)-1-(3,4-dichlorophenyl)-3-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g

3-(3-bromoisoxazol-5-yl)propanoic acid, 10g

4,5,6,7-Tetrahydro-1H-benzoimidazole-5-carboxylic acid hydrochloride, 95.0%, 5g